BAX vs TECH · rev $2.75B vs P/E 65, rev $1.22B
Baxter International Inc (BAX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Baxter International Inc (BAX) is a medical instruments & supplies company listed on NYSE.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported BAX revenue for 2024-12-31 was $2.75B. Net income was -$510.0M. Revenue was up 2.0% from 2024-09-30 to 2024-12-31. BAX currently screens at market cap $10.01B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
BAX currently screens at market cap $10.01B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the BAX and TECH stock pages for the full models.
Not investment advice.